Improved patient adherence to subcutaneous allergen immunotherapy using a modified rush immunotherapy protocol

Despite the efficacy of allergen immunotherapy (AIT), studies demonstrate low compliance rates.1 Adherence during build-up is especially challenging for patients. Rush immunotherapy (RIT) provides a faster method to reach maintenance dose, eliminating several months of build-up, potentially leading to higher patient adherence and accelerated symptom control. Few studies have directly compared the compliance rates of RIT schedules vs conventional schedules in patients from the same office.2 Safety and increased frequency of reaction rate continue to be primary concerns of RIT.

https://ift.tt/2OdKPoL